FMC says expects revenue to almost double by 2020
FRANKFURT, April 3
FRANKFURT, April 3 (Reuters) - Dialysis specialist Fresenius Medical Care said it expected its annual sales to almost double to $28 billion by 2020, driven by a growing number of patients suffering from kidney failure and by acting as coordinator between medical professions.
The target is equivalent to an average annual increase of about 10 percent from $14.6 billion last year, the world's largest dialysis company said in a presentation posted on its website on Thursday as part of its capital markets day. (Reporting by Ludwig Burger; Editing by Christoph Steitz)